2020
DOI: 10.1101/2020.05.12.090720
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Engineering and optimization of the 2-phenylethylglucosinolate production inNicotiana benthamianaby combining biosynthetic genes fromBarbarea vulgarisandArabidopsis thaliana

Abstract: Among the glucosinolate (GLS) defense compounds characteristic of the Brassicales order, several have been shown to promote human health. This includes 2phenylethylglucosinolate (2PE) derived from homophenylalanine (HPhe). In this study, we used transient expression in Nicotiana benthamiana to validate and characterize previously predicted key genes in the 2PE biosynthetic pathway from Barbarea vulgaris and 2 demonstrate the feasibility of engineering 2PE production. We used genes from B. vulgaris and Arabidop… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
2
1

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 58 publications
(62 reference statements)
0
2
0
Order By: Relevance
“…To validate transmembrane domain truncation as a strategy that could be applied to a broad range of P450s, we chose four additional CYP79 enzymes with diverse N-terminal sequences, distinct substrate preferences and different plant origins. CYP79A1 from Sorghum bicolor converts tyrosine into its corresponding oxime (32), CYP79B2 from A. thaliana accepts tryptophan as the sole substrate (33), CYP79D2 from Manihot esculenta acts on both valine and isoleucine (34), and CYP79F6 from Barbarea vulgaris accepts only non-canonical, carbon chain-elongated amino acids (here homophenylalanine) (35). We cloned the four CYP79s, CYP83 and ATR1 into operons where both CYP79 and CYP83 were either native full-length or with the transmembrane domain truncated.…”
Section: Transmembrane Domain Truncation As a Universal Strategy For ...mentioning
confidence: 99%
“…To validate transmembrane domain truncation as a strategy that could be applied to a broad range of P450s, we chose four additional CYP79 enzymes with diverse N-terminal sequences, distinct substrate preferences and different plant origins. CYP79A1 from Sorghum bicolor converts tyrosine into its corresponding oxime (32), CYP79B2 from A. thaliana accepts tryptophan as the sole substrate (33), CYP79D2 from Manihot esculenta acts on both valine and isoleucine (34), and CYP79F6 from Barbarea vulgaris accepts only non-canonical, carbon chain-elongated amino acids (here homophenylalanine) (35). We cloned the four CYP79s, CYP83 and ATR1 into operons where both CYP79 and CYP83 were either native full-length or with the transmembrane domain truncated.…”
Section: Transmembrane Domain Truncation As a Universal Strategy For ...mentioning
confidence: 99%
“…This has primed a desire to engineer the production of health-promoting GLSs to enable a stable and rich source as dietary supplements for the benefit of human health. Biotechnological approaches have been used to engineer and optimize the production of the desirable GLSs (Petersen et al, 2019(Petersen et al, , 2018Wang et al, 2020).…”
Section: Introductionmentioning
confidence: 99%